Coronavirus disease 2019 (COVID-19): research progress and clinical practice
Author:
Affiliation:
1. Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Publisher
National Center for Global Health and Medicine (JST)
Link
https://www.jstage.jst.go.jp/article/ghm/2/2/2_2020.01031/_pdf
Reference68 articles.
1. 1. Isaacs D, Flowers D, Clarke JR, Valman HB, MacNaughton MR. Epidemiology of coronavirus respiratory infections. Arch Dis Child. 1983; 58:500-503.
2. 2. Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol. 2010; 48:2940-2947.
3. 3. Monto AS. Medical reviews. Coronaviruses. Yale J Biol Med. 1974; 47:234-251.
4. 4. Callow KA, Parry HF, Sergeant M, Tyrrell DA. The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect. 1990; 105:435-446.
5. 5. Graat JM, Schouten EG, Heijnen ML, Kok FJ, Pallast EG, de Greeff SC, Dorigo-Zetsma JW. A prospective, community-based study on virologic assessment among elderly people with and without symptoms of acute respiratory infection. J Clin Epidemiol. 2003; 56:1218-1223.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Amino acid catabolite markers for early prognostication of pneumonia in patients with COVID-19;Nature Communications;2023-12-20
2. Evaluation of risk factors associated with SARS-CoV-2 transmission;Current Medical Research and Opinion;2022-10-14
3. Clinical protocol for early treatment of COVID-19 in a real-world scenario: Results of a series of patients;Medicina Clínica Práctica;2022-10
4. Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study;Emerging Microbes & Infections;2022-09-21
5. Safety of convalescent plasma therapy for COVID-19 patients and analysis of viral kinetics: a single-center, open-label, single-arm, interventional study in Japan;GHM Open;2022-08-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3